EventsNews Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression By MacKenzie Lahar | Events, News
News Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation By admin | News
NewsPress Release Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones By admin | News, Press Release
EventsPress Release Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis By admin | Events, Press Release
Press Release Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients By admin | Press Release
NewsPress Release Cortexyme Announces Issuance of Composition of Matter Patent for Atuzaginstat by the U.S. Patent and Trademark Office By admin | News, Press Release
News Cortexyme Announces “Atuzaginstat” Selected as First-in-Class Nonproprietary Name for COR388 By admin | News
